 | Up a level |
Lutz, Manfred P; Zalcberg, John R; Ducreux, Michel; Aust, Daniela; Bruno, Marco J; Büchler, Markus W; Delpero, Jean-Robert; Gloor, Beat; Glynne-Jones, Rob; Hartwig, Werner; Huguet, Florence; Laurent-Puig, Pierre; Lordick, Florian; Maisonneuve, Patrick; Mayerle, Julia; Martignoni, Marc; Neoptolemos, John; Rhim, Andrew D; Schmied, Bruno M; Seufferlein, Thomas; ... (2017). 3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer. European journal of cancer, 79, pp. 41-49. Elsevier 10.1016/j.ejca.2017.03.022
Kunzke, Thomas; Balluff, Benjamin; Feuchtinger, Annette; Buck, Achim; Langer, Rupert; Luber, Birgit; Lordick, Florian; Zitzelsberger, Horst; Aichler, Michaela; Walch, Axel (2017). Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome. OncoTarget, 8(40), pp. 68012-68025. Impact Journals LLC 10.18632/oncotarget.19137
Springfeld, Christoph; Wiecha, Christiane; Kunzmann, Romy; Heger, Ulrike; Weichert, Wilko; Langer, Rupert; Stange, Annika; Blank, Susanne; Sisic, Leila; Schmidt, Thomas; Lordick, Florian; Jäger, Dirk; Grenacher, Lars; Bruckner, Tom; Büchler, Markus W; Ott, Katja (2015). Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma. Annals of surgical oncology, 22(Suppl 3), pp. 905-914. Springer 10.1245/s10434-015-4617-x
Blank, Susanne; Lordick, Florian; Bader, Franz; Burian, Maria; Dobritz, Martin; Grenacher, Lars; Becker, Karen; Weichert, Wilko; Langer, Rupert; Sisic, Leila; Stange, Annika; Jäger, Dirk; Büchler, Markus; Bruckner, Thomas; Siewert, Jörg; Ott, Katja (2015). Post-therapeutic response evaluation by a combination of endoscopy and CT scan in esophagogastric adenocarcinoma after chemotherapy: better than its reputation. Gastric cancer, 18(2), pp. 314-325. Springer 10.1007/s10120-014-0367-x
Karamitopoulou, Evanthia; Thies, Svenja; Zlobec, Inti; Ott, Katja; Feith, Marcus; Slotta-Huspenina, Julia; Lordick, Florian; Becker, Karen; Langer, Rupert (2014). Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches. The American journal of surgical pathology, 38(11), pp. 1551-1556. Lippincott Williams & Wilkins 10.1097/PAS.0000000000000255
Aichler, Michaela; Motschmann, Martin; Jütting, Uta; Luber, Birgit; Becker, Karen; Ott, Katja; Lordick, Florian; Langer, Rupert; Feith, Marcus; Siewert, Jörg Rüdiger; Walch, Axel (2014). Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy. OncoTarget, 5(16), pp. 6620-6632. Impact Journals LLC
Heger, Ulrike; Blank, Susanne; Wiecha, Christiane; Langer, Rupert; Weichert, Wilko; Lordick, Florian; Bruckner, Thomas; Dobritz, Martin; Burian, Maria; Springfeld, Christoph; Grenacher, Lars; Siewert, Jörg-Rüdiger; Büchler, Markus; Ott, Katja (2014). Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach? Annals of surgical oncology, 21(5), pp. 1739-1748. Springer 10.1245/s10434-013-3462-z
Langer, Rupert; Becker, Karen; Zlobec, Inti; Gertler, Ralf; Sisic, Leila; Büchler, Markus; Lordick, Florian; Slotta-Huspenina, Julia; Weichert, Wilko; Höfler, Heinz; Feith, Marcus; Ott, Katja (2014). A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy. Annals of surgical oncology, 21(3), pp. 915-921. Springer 10.1245/s10434-013-3410-y
Heger, Ulrike; Bader, Franz; Lordick, Florian; Burian, Maria; Langer, Rupert; Dobritz, Martin; Blank, Susanne; Bruckner, Thomas; Becker, Karen; Herrmann, Ken; Siewert, Jörg-Rüdiger; Ott, Katja (2014). Interim endoscopy results during neoadjuvant therapy for gastric cancer correlate with histopathological response and prognosis. Gastric cancer, 17(3), pp. 478-488. Springer 10.1007/s10120-013-0296-0
Blank, Susanne; Rachakonda, Sivaramakrishna; Keller, Gisela; Weichert, Wilko; Lordick, Florian; Langer, Rupert; Springfeld, Christoph; Bruckner, Thomas; Becker, Karen; Kumar, Rajiv; Ott, Katja (2014). A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients. BMC cancer, 14(58), p. 58. BioMed Central 10.1186/1471-2407-14-58
Ott, Katja; Blank, Susanne; Becker, Karen; Langer, Rupert; Weichert, Wilko; Roth, Wilfried; Sisic, Leila; Stange, Annika; Jäger, Dirk; Büchler, Markus; Siewert, Jörg-Rüdiger; Lordick, Florian (2012). Factors predicting prognosis and recurrence in patients with esophago-gastric adenocarcinoma and histopathological response with less than 10 % residual tumor. Langenbeck's archives of surgery, 398(2), pp. 239-249. Berlin: Springer 10.1007/s00423-012-1039-0
Cmelak, Anthony J; Lordick, Florian; Borner, Markus; Goldberg, Richard M; Saif, M Wasif (2009). Management of infusion reactions in clinical trials and beyond: the US and EU perspectives. Oncology, 23(2 Suppl 1), pp. 18-25. Norwalk, Conn.: UBM Medica
